Details of Protein
General Information of Protein (ID: PRT00280) | |||||
---|---|---|---|---|---|
Name | Succinate-hydroxymethylglutarate CoA-transferase (SUGCT) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
SuccinylCoA:glutarate-CoA transferase; Sugct
|
||||
Gene Name | Sugct | Gene ID | |||
UniProt ID | |||||
Family | Transferases (EC 2) | ||||
EC Number | EC: 2.8.3.13 (Click to Show/Hide the Complete EC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MLWMLARAVAFRRPGRGLAGGRGLWTGRPQSDCDSMKPLEGVRILDLTRVLAGPFATMNL
GDLGAEVIKVERPGAGDDTRSWGPPFVNTESTYFLSVNRNKKSIAVNIKDPRGVRIVKEL AAICDVFVENYVPGKLSEMGLGYEDIDKIAPHIIYCSITGYGQTGPMSHRAGYDAIASAM SGLMHITGPEDGDPVRPGVAMTDLATGLFAYGAIMAGLLQRYRTGKGLFIDCNLLSSQVA CLTQVAANYLIGQKEAKRWGTAHGSIVPYQAFKTKDGYLVIGAGNNQQFAVVCKILNLPE LIDDCKYRTNHLRVQNRKELVKILSARFAEEVTAKWLCLFEGSGIPYGPINSLKDVFSEA QVLHNGLVMEMNHPTVGKISVPGPAVRYSKFKMSEAKPPPLLGQHTRHILKEVLRYDEGA IEKLLCSGVIEQHETK |
||||
Function | Catalyzes the succinyl-CoA-dependent conversion of glutarate to glutaryl-CoA. Can use different dicarboxylic acids as CoA acceptors, the preferred ones are glutarate, succinate, adipate, and 3-hydroxymethylglutarate. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
FAD | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | FAD concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of FAD levels compared with control group. | |||||
Lipid-related molecules | ||||||
Linoelaidylcarnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Linoelaidylcarnitine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of linoelaidylcarnitine levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
Adipic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Adipic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of adipic acid levels compared with control group. | |||||
cis-5-Tetradecenoylcarnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | cis-5-Tetradecenoylcarnitine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the decrease of cis-5-Tetradecenoylcarnitine levels compared with control group. | |||||
Linoleic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Linoleic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of linoleic acid levels compared with control group. | |||||
Octadec-9-enoic Acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Octadec-9-enoic Acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of octadec-9-enoic Acid levels compared with control group. | |||||
Organic acids | ||||||
Egtazic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Egtazic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of egtazic acid levels compared with control group. | |||||
Organic acids and derivatives | ||||||
Glutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Glutaric acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of glutaric acid levels compared with control group. | |||||
Tyrosyl-Tyrosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Tyrosyl-Tyrosine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of tyrosyl-tyrosine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
Octanal | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Octanal concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of octanal levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
5-Hydroxy-L-tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | 5-Hydroxy-L-tryptophan concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the decrease of 5-hydroxy-L-tryptophan levels compared with control group. | |||||
Riboflavin cyclic-4',5'-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Sugct | |||||
Induced Change | Riboflavin cyclic-4',5'-phosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
Details | It is reported that knockout of Sugct leads to the increase of riboflavin cyclic-4',5'-phosphate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.